TAURIGA SCIENCES INC - TAUG STOCK NEWS

Tauriga Sciences, Inc. (TAUG) has officially launched its Tauri-Gum™ product line on Stock Up Express, a Connecticut-based online grocer and wholesaler. The launch, which went live on February 24, 2021, marks an important step for the company, as Stock Up Express generates over $3 billion in annual sales. Tauri-Gum™ is a CBD and CBG infused supplement chewing gum available in various retail formats. Tauriga anticipates significant revenue contributions from this partnership in Q1 2021, while additional product offerings are planned for future listing.

Tauriga Sciences, Inc. (TAUG) has launched two new products: CBD Infused Linden Honey and Rainbow Bath Bomb Special, available on their E-Commerce platform. The CBD Honey, priced at $49.99 per jar, contains 500mg of CBD, equating to 25mg per serving. The Rainbow Bath Bomb Special, priced at $69.99 for a pack of six, includes various infusions of CBD, CBG, Vitamin C, and Zinc. These products aim to enhance Tauriga's portfolio in the CBD and CBG edibles market as the company continues its pharmaceutical development initiatives.

Tauriga Sciences, Inc. (TAUG) announced a significant increase in its marketing budget to boost its high-margin E-Commerce segment, following record-setting sales in Q3 2021. The company has received over 5,300 E-Commerce orders, with growth accelerating, especially in international markets. Additionally, Tauriga's E-Commerce platform now accepts multiple cryptocurrencies, enhancing its global payment options. The company is also making progress on its cannabinoid-based pharmaceutical grade chewing gum and expects to provide shareholders with a material update soon.

Tauriga Sciences, Inc. (OTCQB: TAUG) will exhibit virtually at the NACS Campus Store Expo 2021 from February 22-26, showcasing its Tauri-Gum™ product line to North American college bookstores. The NACS, representing a $10 Billion industry, connects nearly 4,000 campuses and 1,000 suppliers. Last year, Tauriga had a main floor exhibit at the same event. Their Tauri-Gum™ is a CBD and CBG infused chewing gum offered in various flavors, and the company also pursues a pharmaceutical initiative targeting nausea regulation for chemotherapy patients.

Tauriga Sciences, Inc. (OTCQB: TAUG) has now incorporated cryptocurrency payments, accepting Bitcoin, Ethereum, Bitcoin Cash, Dai, and Litecoin on its E-Commerce platform, aiming to enhance transactions with a global customer base. The company is known for its proprietary CBD and CBG infused chewing gums, branded as Tauri-Gum™, which includes various flavors and is designed to accommodate diverse consumer preferences. Additionally, Tauriga is advancing its pharmaceutical development by working on a version of Tauri-Gum™ aimed at nausea regulation for chemotherapy patients.

Tauriga Sciences, Inc. (OTCQB: TAUG) has announced the development of its first full spectrum Cannabidiol (CBD) infused edibles product line. This product will be Kosher and Halal certified, vegan, dairy-free, with all-natural flavors, and sugar-free options available. The company aims to adhere to U.S. Federal laws and regulations. Tauriga is already known for its Tauri-Gum™ product line and continues to expand its offerings in the CBD and Cannabigerol (CBG) markets. More details regarding the new product line are expected soon.

Tauriga Sciences (OTCQB: TAUG) announced an increased production run of its Tauri-Gum™ product line, featuring enhanced Cannabidiol (CBD) and Cannabigerol (CBG) concentrations of 20mg per gum piece. This strategic move, inspired by a favorable macro-industry outlook, is expected to generate over $1,000,000 in retail value. The company is experiencing heightened interest from retail and wholesale sectors and is focusing on boosting its e-commerce segment. Moreover, Tauriga is enhancing production capabilities to meet rising demand while updating packaging to include certifications and compliance features.

Tauriga Sciences, Inc. (TAUG) has announced that its E-Commerce platform will now accept Bitcoin and possibly other cryptocurrencies, enhancing its ability to transact with customers globally. This move aims to simplify international transactions and protect customers from issues like currency fluctuations and credit card interoperability. The company will convert cryptocurrencies into U.S. Dollars immediately, avoiding speculation on crypto prices. Expanding into international markets is a key corporate goal for 2021.

Tauriga Sciences, Inc. (TAUG) has established two new Universal Product Code (UPC) classifications for its flagship Tauri-Gum™ product line: Tauri-Gum™ Cases (8 Retail Boxes) and Tauri-Gum™ Shipment Crates (48 Retail Boxes). This expansion is aimed at preparing for large wholesale orders and anticipated demand from major retailers. Additionally, the company reports progress in developing a pharmaceutical-grade chewing gum targeted for patients undergoing chemotherapy. A provisional U.S. patent for this product was filed in March 2020.